Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anxiety and Depression: Optimizing Treatments.

James C. Ballenger1

  • 1Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston.

Primary Care Companion to the Journal of Clinical Psychiatry
|March 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care.

Primary care companion to the Journal of clinical psychiatryยท2004
See all related articles

Diagnosing and treating anxiety and depression in primary care is complex due to overlapping symptoms and somatic complaints. Newer antidepressants, including SSRIs and SNRIs, offer improved treatment options for these conditions.

Area of Science:

  • Psychiatry
  • Primary Care Medicine
  • Pharmacology

Background:

  • Diagnosing and treating anxiety and depression in primary care presents challenges due to somatic presentations and symptom overlap.
  • Comorbid anxiety and depression often exhibit treatment resistance and are associated with poorer medical prognoses.

Purpose of the Study:

  • To review the role of newer antidepressant therapies in managing anxiety, depression, and comorbid conditions in primary care.
  • To highlight the importance of individualized treatment strategies based on specific agent profiles.

Main Methods:

  • Review of current literature on newer antidepressant pharmacotherapies.
  • Analysis of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in treating anxiety and depression.

Related Experiment Videos

  • Discussion of factors influencing treatment optimization.

    • Main Results:

    • Newer antidepressants, particularly SSRIs and SNRIs, are increasingly vital for treating anxiety, depression, and comorbid cases.
    • These agents offer potential for sustained complete remission beyond symptom improvement.
    • Individual agent characteristics (efficacy, onset, interactions, tolerability) aid in personalized treatment.

    Conclusions:

    • Selective serotonin reuptuptake inhibitors and serotonin-norepinephrine reuptake inhibitors represent significant advancements in managing primary care patients with anxiety and depression.
    • Individualizing treatment based on drug profiles is crucial for optimizing patient outcomes and achieving remission.